{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:31Z","timestamp":1792806151838,"version":"4.5.0"},"reference-count":30,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"\n OBJECTIVE<\/jats:title>\n Intravenous (IV) milrinone is a promising option for the treatment of cerebral vasospasm with delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). However, data remain limited on the efficacy of treating cases that are refractory to standard therapy with IV milrinone. The aim of this study was to determine predictors of refractory vasospasm\/DCI despite treatment with IV milrinone, and to analyze the outcome of rescue therapy with intraarterial (IA) milrinone and\/or mechanical angioplasty.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n The authors conducted a retrospective cohort study of all patients with aSAH admitted between 2010 and 2016 to the Montreal Neurological Institute and Hospital. Patients were stratified into 3 groups: no DCI, standard therapy, and rescue therapy. The primary outcome was frequency of DCI-related cerebral infarction identified on neuroimaging before hospital discharge. Secondary outcomes included functional outcome reported as modified Rankin Scale (mRS) score, and segment reversal of refractory vasospasm.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n The cohort included 322 patients: 212 in the no DCI group, 89 in the standard therapy group, and 21 in the rescue therapy group. Approximately half (52%, 168\/322) were admitted with poor-grade aSAH at treatment decision (World Federation of Neurosurgical Societies grade III\u2013V). Among patients with DCI and imaging assessing severity of vasospasm, 62% (68\/109) had moderate\/severe radiological vasospasm on DCI presentation. Nineteen percent (21\/110) of patients had refractory vasospasm\/DCI and were treated with rescue therapy. Targeted rescue therapy with IA milrinone reversed 32% (29\/91) of the refractory vasospastic vessels, and 76% (16\/21) of those patients experienced significant improvement in their neurological status within 24 hours of initiating therapy. Moderate\/severe radiological vasospasm independently predicted the need for rescue therapy (OR 27, 95% CI 8.01\u2013112). Of patients with neuroimaging before discharge, 40% (112\/277) had developed new cerebral infarcts, and only 21% (23\/112) of these were vasospasm-related. Overall, 65% (204\/314) of patients had a favorable functional outcome (mRS score 0\u20132) assessed at a median of 4 months (interquartile range 2\u20138 months) after aSAH, and there was no difference in functional outcome between the 3 groups (p = 0.512).<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n The aggressive use of milrinone was safe and effective based on this retrospective study cohort and is a promising therapy for the treatment of vasospasm\/DCI after aSAH.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2020.1.jns193107","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T20:48:41Z","timestamp":1585342121000},"page":"971-982","source":"Crossref","is-referenced-by-count":54,"title":["Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia"],"prefix":"10.3171","volume":"134","author":[{"given":"Yasser B.","family":"Abulhasan","sequence":"first","affiliation":[{"name":"Neurological Intensive Care Unit and"},{"name":"Faculty of Medicine, Health Sciences Center, Kuwait University, Kuwait; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Ortiz Jimenez","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Teitelbaum","sequence":"additional","affiliation":[{"name":"Neurological Intensive Care Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Simoneau","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Angle","sequence":"additional","affiliation":[{"name":"Neurological Intensive Care Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"3","key":"b1","series-title":"Circulation","first-page":"e28","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go AS","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28\u2013e292.24352519"},{"issue":"4","key":"b2","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMra052732","article-title":"Aneurysmal subarachnoid hemorrhage","volume":"354","author":"Suarez JI","year":"2006","unstructured":"Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354(4):387\u2013396.1643677010.1056\/NEJMra052732"},{"key":"b3","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/j.wneu.2018.04.061","article-title":"Health care-associated infections after subarachnoid hemorrhage","volume":"115","author":"Abulhasan YB","year":"2018","unstructured":"Abulhasan YB, Alabdulraheem N, Schiller I, Health care-associated infections after subarachnoid hemorrhage. World Neurosurg. 2018;115:e393\u2013e403.2967871110.1016\/j.wneu.2018.04.061"},{"issue":"2","key":"b4","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","article-title":"Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\u2019s Multidisciplinary Consensus Conference","volume":"15","author":"Diringer MN","year":"2011","unstructured":"Diringer MN, Bleck TP, Hemphill JC III, Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\u2019s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211\u2013240.2177387310.1007\/s12028-011-9605-9"},{"issue":"10","key":"b5","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen MD","year":"2010","unstructured":"Vergouwen MD, Vermeulen M, van Gijn J, Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391\u20132395.2079837010.1161\/STROKEAHA.110.589275"},{"issue":"1","key":"b6","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/STROKEAHA.112.674291","article-title":"Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors","volume":"44","author":"de Rooij NK","year":"2013","unstructured":"de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke. 2013;44(1):43\u201354.2325099710.1161\/STROKEAHA.112.674291"},{"issue":"4","key":"b7","series-title":"Neurosurgery","first-page":"723","article-title":"Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases","volume":"48","author":"Arakawa Y","year":"2001","unstructured":"Arakawa Y, Kikuta K, Hojo M, Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48(4):723\u2013730.11322432"},{"issue":"6","key":"b8","series-title":"Interv Neuroradiol","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/1591019917732288","article-title":"Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm","volume":"23","author":"Duman E","year":"2017","unstructured":"Duman E, Karako\u00e7 F, Pinar HU, Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm. Interv Neuroradiol. 2017;23(6):636\u2013643.2895651210.1177\/1591019917732288"},{"issue":"3","key":"b9","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/STROKEAHA.107.492447","article-title":"Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"39","author":"Fraticelli AT","year":"2008","unstructured":"Fraticelli AT, Cholley BP, Losser MR, Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39(3):893\u2013898.1823918210.1161\/STROKEAHA.107.492447"},{"issue":"2","key":"b10","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12028-008-9048-0","article-title":"Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage","volume":"11","author":"Romero CM","year":"2009","unstructured":"Romero CM, Morales D, Reccius A, Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;11(2):165\u2013171.1820292310.1007\/s12028-008-9048-0"},{"issue":"2","key":"b11","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00234-010-0720-7","article-title":"Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage","volume":"53","author":"Shankar JJ","year":"2011","unstructured":"Shankar JJ, dos Santos MP, Deus-Silva L, Lum C. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology. 2011;53(2):123\u2013128.2054949810.1007\/s00234-010-0720-7"},{"issue":"2","key":"b12","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1017\/cjn.2016.316","article-title":"The use of milrinone in patients with delayed cerebral ischemia following subarachnoid hemorrhage: a systematic review","volume":"44","author":"Lannes M","year":"2017","unstructured":"Lannes M, Zeiler F, Guichon C, Teitelbaum J. The use of milrinone in patients with delayed cerebral ischemia following subarachnoid hemorrhage: a systematic review. Can J Neurol Sci. 2017;44(2):152\u2013160.2784261510.1017\/cjn.2016.316"},{"issue":"3","key":"b13","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12028-012-9701-5","article-title":"Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol","volume":"16","author":"Lannes M","year":"2012","unstructured":"Lannes M, Teitelbaum J, del Pilar Cort\u00e9s M, Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol. Neurocrit Care. 2012;16(3):354\u2013362.2252827810.1007\/s12028-012-9701-5"},{"issue":"3","key":"b14","series-title":"J Neurosurg Anesthesiol","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/ANA.0000000000000527","article-title":"Which protocol for milrinone to treat cerebral vasospasm associated with subarachnoid hemorrhage?","volume":"31","author":"Crespy T","year":"2019","unstructured":"Crespy T, Heintzelmann M, Chiron C, Which protocol for milrinone to treat cerebral vasospasm associated with subarachnoid hemorrhage? J Neurosurg Anesthesiol. 2019;31(3):323\u2013329.3001569410.1097\/ANA.0000000000000527"},{"key":"b15","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1016\/j.wneu.2018.01.160","article-title":"Mortality after spontaneous subarachnoid hemorrhage: causality and validation of a prediction model","volume":"112","author":"Abulhasan YB","year":"2018","unstructured":"Abulhasan YB, Alabdulraheem N, Simoneau G, Mortality after spontaneous subarachnoid hemorrhage: causality and validation of a prediction model. World Neurosurg. 2018;112:e799\u2013e811.2941017410.1016\/j.wneu.2018.01.160"},{"issue":"2","key":"b16","series-title":"AJNR Am J Neuroradiol","first-page":"370","article-title":"Multidetector-row CT angiography of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: comparison of volume-rendered images and digital subtraction angiography","volume":"27","author":"Yoon DY","year":"2006","unstructured":"Yoon DY, Choi CS, Kim KH, Cho BM. Multidetector-row CT angiography of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: comparison of volume-rendered images and digital subtraction angiography. AJNR Am J Neuroradiol. 2006;27(2):370\u2013377.16484413"},{"key":"b17","series-title":"Diagnostic Ultrasound","first-page":"552","article-title":"Diagnostic criteria for transcranial doppler ultrasound","author":"Lao A","year":"2008","unstructured":"Lao A, Sharma VK, Katz ML, Alexandrov AV. Diagnostic criteria for transcranial doppler ultrasound. In: McGahan JP, Goldberg BB, eds. Diagnostic Ultrasound. 2nd ed. New York: Informa Healthcare; 2008:552\u2013554."},{"issue":"12","key":"b18","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/jnnp.2006.089748","article-title":"Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage","volume":"77","author":"Naidech AM","year":"2006","unstructured":"Naidech AM, Drescher J, Tamul P, Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2006;77(12):1340\u20131344.1682041910.1136\/jnnp.2006.089748"},{"issue":"3","key":"b19","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00234-011-0876-9","article-title":"CT angiography for evaluation of cerebral vasospasm following acute subarachnoid haemorrhage","volume":"54","author":"Shankar JJ","year":"2012","unstructured":"Shankar JJ, Tan IY, Krings T, CT angiography for evaluation of cerebral vasospasm following acute subarachnoid haemorrhage. Neuroradiology. 2012;54(3):197\u2013203.2154168710.1007\/s00234-011-0876-9"},{"issue":"1","key":"b20","series-title":"J R Stat Soc B","first-page":"289","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini Y","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57(1):289\u2013300."},{"issue":"3\u20134","key":"b21","series-title":"Health Serv Outcomes Res Methodol","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1020363010465","article-title":"Using propensity scores to help design observational studies: application to the tobacco litigation","volume":"2","author":"Rubin DB","year":"2001","unstructured":"Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3\u20134):169\u2013188.10.1023\/A:1020363010465"},{"issue":"7","key":"b22","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1161\/STROKEAHA.118.022536","article-title":"Medical treatment failure for symptomatic vasospasm after subarachnoid hemorrhage threatens long-term outcome","volume":"50","author":"Suwatcharangkoon S","year":"2019","unstructured":"Suwatcharangkoon S, De Marchis GM, Witsch J, Medical treatment failure for symptomatic vasospasm after subarachnoid hemorrhage threatens long-term outcome. Stroke. 2019;50(7):1696\u20131702.3116406810.1161\/STROKEAHA.118.022536"},{"issue":"2","key":"b23","series-title":"Curr Opin Crit Care","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00075198-200204000-00007","article-title":"Therapeutic approaches to vasospasm in subarachnoid hemorrhage","volume":"8","author":"Dorsch NW","year":"2002","unstructured":"Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care. 2002;8(2):128\u2013133.1238651310.1097\/00075198-200204000-00007"},{"issue":"1","key":"b24","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3171\/2014.12.JNS13846","article-title":"Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study","volume":"124","author":"Ehlert A","year":"2016","unstructured":"Ehlert A, Schmidt C, W\u00f6lfer J, Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. J Neurosurg. 2016;124(1):51\u201358.2616203410.3171\/2014.12.JNS13846"},{"issue":"1","key":"b25","series-title":"Pharmacol Ther","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2004.10.002","article-title":"Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment","volume":"105","author":"Pluta RM","year":"2005","unstructured":"Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005;105(1):23\u201356.1562645410.1016\/j.pharmthera.2004.10.002"},{"issue":"4","key":"b26","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/STROKEAHA.110.597914","article-title":"Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects","volume":"42","author":"Vergouwen MD","year":"2011","unstructured":"Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42(4):924\u2013929.2131106210.1161\/STROKEAHA.110.597914"},{"key":"b27","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.wneu.2016.09.096","article-title":"Predictors of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage with asymptomatic angiographic vasospasm on admission","volume":"97","author":"Aldakkan A","year":"2017","unstructured":"Aldakkan A, Mansouri A, Jaja BN, Predictors of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage with asymptomatic angiographic vasospasm on admission. World Neurosurg. 2017;97:199\u2013204.2771777610.1016\/j.wneu.2016.09.096"},{"issue":"2","key":"b28","series-title":"Neurosurg Clin N Am","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.nec.2009.10.006","article-title":"Risk factors and medical management of vasospasm after subarachnoid hemorrhage","volume":"21","author":"Lazaridis C","year":"2010","unstructured":"Lazaridis C, Naval N. Risk factors and medical management of vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21(2):353\u2013364.2038097510.1016\/j.nec.2009.10.006"},{"issue":"6","key":"b29","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3171\/2018.1.JNS172715","article-title":"Clinical prediction of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage","volume":"130","author":"Lee H","year":"2018","unstructured":"Lee H, Perry JJ, English SW, Clinical prediction of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2018;130(6):1914\u20131921.10.3171\/2018.1.JNS172715"},{"key":"b30","series-title":"ClinicalTrials.gov","article-title":"Milrinone in addition to hyperdynamic therapy in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage","author":"Shapiro S","unstructured":"Shapiro S. Milrinone in addition to hyperdynamic therapy in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02712788. Accessed February 4, 2020."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/134\/3\/article-p971.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/134\/3\/article-p971.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/134\/3\/article-p971.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:53:24Z","timestamp":1792803204000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/134\/3\/article-p971.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":30,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2020.1.jns193107","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}